IL33 and glioma: To extend these results, we used an independent cohort of GBM specimens (tissue microarray (TMA) containing 70 patient specimens) and found that 12/64 (18.8%) had high IL-33 expression that was predominately localized within the nucleus of glioma cells (Fig. 2d, left panel).